chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Ear pain, Headache, Impaired work ability, Muscular weakness
Clinical narrative: pain that went down to her legs; headaches; earaches; fever; chills; arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job; body aches; left leg nerve pain; weakness in the patient's hand; arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job; Caller states his daughter was suppose to receive 0.3 ml of the vaccine but she received 0.8 ml of the vaccine; This is a spontaneous report from a contactable consumer or other non hcp.   A 22-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6205, expiration date: not reported) via an unspecified route of administration, administered in Left arm on 26Feb2021 at around noon, 11:45 (at the age of 22-years-old) as dose 1, 0.8 ml single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. No family medical history relevant to AE. History of all previous immunization with the Pfizer vaccine considered as suspect was not reported. Neither received Prior Vaccinations (within 4 weeks) nor AE(s) following prior vaccinations. On 26Feb2021, patient stated that his daughter was suppose to receive 0.3 ml of the vaccine but she received 0.8 ml of the vaccine (Overdose), On an unspecified date, patient experienced pain that went down to her legs, headaches, earaches, fever, chills, arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job, body aches, left leg nerve pain, weakness in the patient's hand. Patient took treatment of prednisone for 5 days. The outcome of event for arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job was not recovered. outcome of his daughter was suppose to receive 0.3 ml of the vaccine but she received 0.8 ml of the vaccine was unknown and rest all events outcome was recovered in an unspecified date of 2021.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neuralgia, Overdose, Pain, Pain in extremity, Pyrexia
Clinical narrative: pain that went down to her legs; headaches; earaches; fever; chills; arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job; body aches; left leg nerve pain; weakness in the patient's hand; arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job; Caller states his daughter was suppose to receive 0.3 ml of the vaccine but she received 0.8 ml of the vaccine; This is a spontaneous report from a contactable consumer or other non hcp.   A 22-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6205, expiration date: not reported) via an unspecified route of administration, administered in Left arm on 26Feb2021 at around noon, 11:45 (at the age of 22-years-old) as dose 1, 0.8 ml single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. No family medical history relevant to AE. History of all previous immunization with the Pfizer vaccine considered as suspect was not reported. Neither received Prior Vaccinations (within 4 weeks) nor AE(s) following prior vaccinations. On 26Feb2021, patient stated that his daughter was suppose to receive 0.3 ml of the vaccine but she received 0.8 ml of the vaccine (Overdose), On an unspecified date, patient experienced pain that went down to her legs, headaches, earaches, fever, chills, arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job, body aches, left leg nerve pain, weakness in the patient's hand. Patient took treatment of prednisone for 5 days. The outcome of event for arm pain that migrated to her hand and causing her not to be able to work the equipment at her physical therapy job was not recovered. outcome of his daughter was suppose to receive 0.3 ml of the vaccine but she received 0.8 ml of the vaccine was unknown and rest all events outcome was recovered in an unspecified date of 2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Ocular hyperaemia
Clinical narrative: dry itchy eyes; dry itchy eyes; swollen red irritated eyes; swollen red irritated eyes; This is a spontaneous report from a contactable consumer (patient herself). A 59-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number EN6199), via an unspecified route of administration, administered in Arm Left on 06Mar2021 13:00 (at the age of 59 years old )as dose 1, single for COVID-19 immunization. Medical history included ongoing hypertension (It's been 4 to 5 years), asthma (It's been 4 to 5 years), gastroesophageal reflux disease (I do not think that is an issue but I just thought to bring it out but I might have GERD). Concomitant medication(s) included HYDROCHLOROTHIAZIDE taken for hypertension daily once, ALBUTEROL SULFATE. Last year she had a bunch of vaccine, she usually do not do vaccine but with the COVID she thought do her vaccine. So, she did the flu vaccine, shingles vaccine and pneumonia vaccine and she was fine with all those vaccine, at the end of the year. No pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She had the 1st vaccine shot on March 6th and she did had a reaction and just wanted to know if she was okay to get the second shot. The patient reaction was like three hours after this shot on 06Mar2021 at 16:00 dry itchy eyes and swollen red irritated eyes. It was reported that her eyes started bothering her, very irritated and dry. The patient did not think anything about it till the next morning when her eyes were swollen, red and very irritating. She kind of like searched online it in the afternoon. The patient know this is a reaction, she do not have eye issues like she do not have dry eye issue. So that day she had put her cold compresses on and in the afternoon she ended up taking an anti-histamine and said on Saturday she got the shot and Saturday late afternoon and started having some issues, Sunday morning it definitely 'flared off' and then Monday morning she was totally fine so, a day and half of the irritation but just wanted to make sure that is not going to be worse with the second shot. She did go online that day and filled out information on the website and today she just saw that the same information on the Pfizer website. The patient reported that the patient only take the inhaler before exercising and she do not do it all the time and just do it when she feel like she having trouble breathing or it is not very consistent. She do not take it a lot. On 06Mar2021 16:00 the patient experienced dry itchy eyes and swollen red irritated eyes. The patient underwent lab tests and procedures which included sars-cov-2 test (rapid test) COVID test type-Nasal Swab and result was negative on 13Mar2021. Therapeutic measures were taken as a result for all the events. The outcome of the events was recovered.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry eye, Eye pruritus, Eye swelling, Ocular hyperaemia, SARS-CoV-2 test
Clinical narrative: dry itchy eyes; dry itchy eyes; swollen red irritated eyes; swollen red irritated eyes; This is a spontaneous report from a contactable consumer (patient herself). A 59-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number EN6199), via an unspecified route of administration, administered in Arm Left on 06Mar2021 13:00 (at the age of 59 years old )as dose 1, single for COVID-19 immunization. Medical history included ongoing hypertension (It's been 4 to 5 years), asthma (It's been 4 to 5 years), gastroesophageal reflux disease (I do not think that is an issue but I just thought to bring it out but I might have GERD). Concomitant medication(s) included HYDROCHLOROTHIAZIDE taken for hypertension daily once, ALBUTEROL SULFATE. Last year she had a bunch of vaccine, she usually do not do vaccine but with the COVID she thought do her vaccine. So, she did the flu vaccine, shingles vaccine and pneumonia vaccine and she was fine with all those vaccine, at the end of the year. No pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She had the 1st vaccine shot on March 6th and she did had a reaction and just wanted to know if she was okay to get the second shot. The patient reaction was like three hours after this shot on 06Mar2021 at 16:00 dry itchy eyes and swollen red irritated eyes. It was reported that her eyes started bothering her, very irritated and dry. The patient did not think anything about it till the next morning when her eyes were swollen, red and very irritating. She kind of like searched online it in the afternoon. The patient know this is a reaction, she do not have eye issues like she do not have dry eye issue. So that day she had put her cold compresses on and in the afternoon she ended up taking an anti-histamine and said on Saturday she got the shot and Saturday late afternoon and started having some issues, Sunday morning it definitely 'flared off' and then Monday morning she was totally fine so, a day and half of the irritation but just wanted to make sure that is not going to be worse with the second shot. She did go online that day and filled out information on the website and today she just saw that the same information on the Pfizer website. The patient reported that the patient only take the inhaler before exercising and she do not do it all the time and just do it when she feel like she having trouble breathing or it is not very consistent. She do not take it a lot. On 06Mar2021 16:00 the patient experienced dry itchy eyes and swollen red irritated eyes. The patient underwent lab tests and procedures which included sars-cov-2 test (rapid test) COVID test type-Nasal Swab and result was negative on 13Mar2021. Therapeutic measures were taken as a result for all the events. The outcome of the events was recovered.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral normal, Asthenia, Cerebrovascular accident, Computerised tomogram head abnormal, Headache
Clinical narrative: Patient developed severe headache with nausea and vomiting - while en route to the hospital she developed sudden right lower extremity paralysis and numbness.  CT head and neck showed absent or severely hypoplastic A1 segment left anterior cerebral artery.  Stroke alert initiated and she received tPA.  She had an MRI the next morning showing no stroke. She was discharged to rehab for her R sided weakness and has recovered nearly fully over 6+ months.  Unclear etiology for the onset of her symptoms given negative MRI.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Monoplegia, Nausea, Paraesthesia, Vomiting
Clinical narrative: Patient developed severe headache with nausea and vomiting - while en route to the hospital she developed sudden right lower extremity paralysis and numbness.  CT head and neck showed absent or severely hypoplastic A1 segment left anterior cerebral artery.  Stroke alert initiated and she received tPA.  She had an MRI the next morning showing no stroke. She was discharged to rehab for her R sided weakness and has recovered nearly fully over 6+ months.  Unclear etiology for the onset of her symptoms given negative MRI.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Cerebellar hypoplasia, Computerised tomogram head abnormal, Computerised tomogram neck, Headache
Clinical narrative: Patient developed severe headache with nausea and vomiting - while en route to the hospital she developed sudden right lower extremity paralysis and numbness.  CT head and neck showed absent or severely hypoplastic A1 segment left anterior cerebral artery.  Stroke alert initiated and she received tPA.  She had an MRI the next morning showing no stroke. She was discharged to rehab for her R sided weakness and has recovered nearly fully over 6+ months.  Unclear etiology for the onset of her symptoms given negative MRI.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hemiparesis, Hemiplegia, Hypoaesthesia, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal
Clinical narrative: Patient developed severe headache with nausea and vomiting - while en route to the hospital she developed sudden right lower extremity paralysis and numbness.  CT head and neck showed absent or severely hypoplastic A1 segment left anterior cerebral artery.  Stroke alert initiated and she received tPA.  She had an MRI the next morning showing no stroke. She was discharged to rehab for her R sided weakness and has recovered nearly fully over 6+ months.  Unclear etiology for the onset of her symptoms given negative MRI.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Monoplegia, Nausea, Scan with contrast abnormal, Vomiting
Clinical narrative: Patient developed severe headache with nausea and vomiting - while en route to the hospital she developed sudden right lower extremity paralysis and numbness.  CT head and neck showed absent or severely hypoplastic A1 segment left anterior cerebral artery.  Stroke alert initiated and she received tPA.  She had an MRI the next morning showing no stroke. She was discharged to rehab for her R sided weakness and has recovered nearly fully over 6+ months.  Unclear etiology for the onset of her symptoms given negative MRI.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Chills, Erythema, Musculoskeletal discomfort, Swelling face
Clinical narrative: Face felt really hot and I was looking in the mirror and my face was really red; Noticed that the left side of my face looks swollen, and that's the same side I got the vaccine on; half of it was swollen; Face felt really hot and I was looking in the mirror and my face was really red; This is a spontaneous report from a contactable consumer (patient herself). A 46 year old female patient had received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/lot number: EN6204, Expiry Date: Unknown) via an unspecified route of administration in upper arm left on 16Mar2021 as a DOSE 1, SINGLE for covid-19 immunization (at age of 46 years old). Other Products and patient history were reported as none. The patient concomitant medication were not reported. On16Mar2021 the patient had experienced Face felt really hot and I was looking in the mirror and my face was really red and noticed that the left side of my face looks swollen, and that's the same side I got the vaccine on; half of it was swollen and reported that I did not have the shortness of breath or anything. Reporter stated, "The question I had if I could get the second shot and I checked with my doctor and they did not know, when I got my first shot, I felt fine but, on my way, home my face felt really hot, and I was looking in the mirror and my face was really red. But then when I actually got home my daughter noticed that the left side of my face looks swollen, and that's the same side I got the vaccine on. I did not have the shortness of breath or anything. It was on same day, yeah." Reporter confirmed the name of the vaccine as Pfizer COVID 19 Vaccine. Reporter stated, "Yeah, just half of it was swollen." Due date for the next shot was reported as 06Apr2021. Consumer stated, I took one dose of Benadryl when I came home, children Benadryl (taken as a treatment), Formulation Syrup. For the indication of reported as "Because of the redness on my face." When confirmed that was because of the COVID 19 Vaccine, reporter stated, "Right because I didn't know if I had an allergic reaction." Consumer stated, "No, it was gone the next, oh the redness was gone on that day and the swelling was gone the next day." Reporter seriousness for the events were unspecified. The clinical outcome of all the events were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Feeling hot, Swelling face
Clinical narrative: Face felt really hot and I was looking in the mirror and my face was really red; Noticed that the left side of my face looks swollen, and that's the same side I got the vaccine on; half of it was swollen; Face felt really hot and I was looking in the mirror and my face was really red; This is a spontaneous report from a contactable consumer (patient herself). A 46 year old female patient had received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/lot number: EN6204, Expiry Date: Unknown) via an unspecified route of administration in upper arm left on 16Mar2021 as a DOSE 1, SINGLE for covid-19 immunization (at age of 46 years old). Other Products and patient history were reported as none. The patient concomitant medication were not reported. On16Mar2021 the patient had experienced Face felt really hot and I was looking in the mirror and my face was really red and noticed that the left side of my face looks swollen, and that's the same side I got the vaccine on; half of it was swollen and reported that I did not have the shortness of breath or anything. Reporter stated, "The question I had if I could get the second shot and I checked with my doctor and they did not know, when I got my first shot, I felt fine but, on my way, home my face felt really hot, and I was looking in the mirror and my face was really red. But then when I actually got home my daughter noticed that the left side of my face looks swollen, and that's the same side I got the vaccine on. I did not have the shortness of breath or anything. It was on same day, yeah." Reporter confirmed the name of the vaccine as Pfizer COVID 19 Vaccine. Reporter stated, "Yeah, just half of it was swollen." Due date for the next shot was reported as 06Apr2021. Consumer stated, I took one dose of Benadryl when I came home, children Benadryl (taken as a treatment), Formulation Syrup. For the indication of reported as "Because of the redness on my face." When confirmed that was because of the COVID 19 Vaccine, reporter stated, "Right because I didn't know if I had an allergic reaction." Consumer stated, "No, it was gone the next, oh the redness was gone on that day and the swelling was gone the next day." Reporter seriousness for the events were unspecified. The clinical outcome of all the events were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Pyrexia, Systemic inflammatory response syndrome
Clinical narrative: Hospitalized (9.29.21);  COVID-19 positive (9.29.21);  fully vaccinated  Discharge Provider:  DO Primary Care Provider:  MD Admission Date: 9/29/2021 Discharge Date: Oct 3, 2021 HOSPITAL COURSE 59-year-old gentleman presented to the ER complaining of increasing shortness of breath, cough, fatigue, body aches, dizziness.  Was febrile temp 38.1°.  Chest x-ray was negative.  COVID test positive.  Hypoxic at 83% on room air.  Admitted with a diagnosis of COVID.  Treated with five days Remdesivir, five days Decadron.  Symptoms improved.  At discharge SpO2 87% on room air at rest, 97% on 1 L with exertion.  Oxygen prescribed at discharge.  The patient does not really think he needs it but accepted it.  He will complete another five days of Decadron at discharge.  Patient stable for discharge today.   Exam 36.5°, 52, 16, 139/72, 91% 1 L at rest 59-year-old male alert and oriented x3 Heart regular rate and rhythm Lungs clear to auscultation Abdomen nondistended nontender Extremities trace nonpitting edema.   Discharge recommendations 1. Wear oxygen 1 liter/minute until SpO2 90% or greater 2. Follow up with Dr.  October 11 3. Diabetic diet 4. Activity as tolerated  Patient discharged home in improved and stable condition
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Dizziness, Dyspnoea
Clinical narrative: Hospitalized (9.29.21);  COVID-19 positive (9.29.21);  fully vaccinated  Discharge Provider:  DO Primary Care Provider:  MD Admission Date: 9/29/2021 Discharge Date: Oct 3, 2021 HOSPITAL COURSE 59-year-old gentleman presented to the ER complaining of increasing shortness of breath, cough, fatigue, body aches, dizziness.  Was febrile temp 38.1°.  Chest x-ray was negative.  COVID test positive.  Hypoxic at 83% on room air.  Admitted with a diagnosis of COVID.  Treated with five days Remdesivir, five days Decadron.  Symptoms improved.  At discharge SpO2 87% on room air at rest, 97% on 1 L with exertion.  Oxygen prescribed at discharge.  The patient does not really think he needs it but accepted it.  He will complete another five days of Decadron at discharge.  Patient stable for discharge today.   Exam 36.5°, 52, 16, 139/72, 91% 1 L at rest 59-year-old male alert and oriented x3 Heart regular rate and rhythm Lungs clear to auscultation Abdomen nondistended nontender Extremities trace nonpitting edema.   Discharge recommendations 1. Wear oxygen 1 liter/minute until SpO2 90% or greater 2. Follow up with Dr.  October 11 3. Diabetic diet 4. Activity as tolerated  Patient discharged home in improved and stable condition
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypoxia, Non-pitting oedema, Pain, Pyrexia
Clinical narrative: Hospitalized (9.29.21);  COVID-19 positive (9.29.21);  fully vaccinated  Discharge Provider:  DO Primary Care Provider:  MD Admission Date: 9/29/2021 Discharge Date: Oct 3, 2021 HOSPITAL COURSE 59-year-old gentleman presented to the ER complaining of increasing shortness of breath, cough, fatigue, body aches, dizziness.  Was febrile temp 38.1°.  Chest x-ray was negative.  COVID test positive.  Hypoxic at 83% on room air.  Admitted with a diagnosis of COVID.  Treated with five days Remdesivir, five days Decadron.  Symptoms improved.  At discharge SpO2 87% on room air at rest, 97% on 1 L with exertion.  Oxygen prescribed at discharge.  The patient does not really think he needs it but accepted it.  He will complete another five days of Decadron at discharge.  Patient stable for discharge today.   Exam 36.5°, 52, 16, 139/72, 91% 1 L at rest 59-year-old male alert and oriented x3 Heart regular rate and rhythm Lungs clear to auscultation Abdomen nondistended nontender Extremities trace nonpitting edema.   Discharge recommendations 1. Wear oxygen 1 liter/minute until SpO2 90% or greater 2. Follow up with Dr.  October 11 3. Diabetic diet 4. Activity as tolerated  Patient discharged home in improved and stable condition
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Hospitalized (9.29.21);  COVID-19 positive (9.29.21);  fully vaccinated  Discharge Provider:  DO Primary Care Provider:  MD Admission Date: 9/29/2021 Discharge Date: Oct 3, 2021 HOSPITAL COURSE 59-year-old gentleman presented to the ER complaining of increasing shortness of breath, cough, fatigue, body aches, dizziness.  Was febrile temp 38.1°.  Chest x-ray was negative.  COVID test positive.  Hypoxic at 83% on room air.  Admitted with a diagnosis of COVID.  Treated with five days Remdesivir, five days Decadron.  Symptoms improved.  At discharge SpO2 87% on room air at rest, 97% on 1 L with exertion.  Oxygen prescribed at discharge.  The patient does not really think he needs it but accepted it.  He will complete another five days of Decadron at discharge.  Patient stable for discharge today.   Exam 36.5°, 52, 16, 139/72, 91% 1 L at rest 59-year-old male alert and oriented x3 Heart regular rate and rhythm Lungs clear to auscultation Abdomen nondistended nontender Extremities trace nonpitting edema.   Discharge recommendations 1. Wear oxygen 1 liter/minute until SpO2 90% or greater 2. Follow up with Dr.  October 11 3. Diabetic diet 4. Activity as tolerated  Patient discharged home in improved and stable condition
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Skin irritation, Urticaria
Clinical narrative: Rash; red/irritated skin; red/irritated skin; itchy skin all over both legs, front and back; hives; This is a spontaneous report from contactable consumer. This 27-years-old female (Patient) reported for herself.  A 27-years-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP7534), via an unspecified route of administration, administered in Right arm on 21Mar2021 04:00 am (27-years-old at the time of vaccination) as dose 1, single for covid-19 immunisation. The medical history was not reported. The patient concomitant medications were not reported. The patient previously received Penicillin (PENICILLIN [PENICILLIN NOS]), Amoxicillin (AMOXICILLIN) and Azithromycin (AZITHROMYCIN) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Prior to Covid vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date on Mar2021, the patient experienced rash, red/irritated skin, itchy skin all over both legs, front and back and hives. The patient did not receive any treatment. The outcome of the events was recovered on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pruritus, Rash, Skin irritation, Urticaria
Clinical narrative: Rash; red/irritated skin; red/irritated skin; itchy skin all over both legs, front and back; hives; This is a spontaneous report from contactable consumer. This 27-years-old female (Patient) reported for herself.  A 27-years-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP7534), via an unspecified route of administration, administered in Right arm on 21Mar2021 04:00 am (27-years-old at the time of vaccination) as dose 1, single for covid-19 immunisation. The medical history was not reported. The patient concomitant medications were not reported. The patient previously received Penicillin (PENICILLIN [PENICILLIN NOS]), Amoxicillin (AMOXICILLIN) and Azithromycin (AZITHROMYCIN) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Prior to Covid vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date on Mar2021, the patient experienced rash, red/irritated skin, itchy skin all over both legs, front and back and hives. The patient did not receive any treatment. The outcome of the events was recovered on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Ear pain, Fatigue, Lymphoedema, Nausea
Clinical narrative: Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; This is a spontaneous report from a contactable other healthcare professional (patient). A 68-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration, administered in Arm Right on 18Mar2021 14:00 (at the age of 68-year-old) as single dose for covid-19 immunization. Medical history included Sepsis one year ago (2020), known allergies to eggs. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included melatonin taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5198), via an unspecified route of administration, administered in Arm Right on 25Feb2021 14:00 (at the age of 68-year-old) for covid-19 immunization. The patient also took hydromorphone (DILAUDID), levofloxacin (LEVAQUIN) and alendronic acid (FOSAMAX) before and had allergy. The patient experienced fever and chills the next day on 19Mar2021 6.00AM - lymphadenopathy of neck and throat on the 2nd day (20Mar2021) - throat ulcers and ear pain on the third day (21Mar2021). The largest ulcer was about the size of a quarter. Continued low grade fever and pain and ulceration. AE resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient did not receive any treatment for AE. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab (pending results) on 22Mar2021. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal ulceration, Pyrexia, SARS-CoV-2 test, Stomatitis
Clinical narrative: Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; This is a spontaneous report from a contactable other healthcare professional (patient). A 68-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration, administered in Arm Right on 18Mar2021 14:00 (at the age of 68-year-old) as single dose for covid-19 immunization. Medical history included Sepsis one year ago (2020), known allergies to eggs. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included melatonin taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5198), via an unspecified route of administration, administered in Arm Right on 25Feb2021 14:00 (at the age of 68-year-old) for covid-19 immunization. The patient also took hydromorphone (DILAUDID), levofloxacin (LEVAQUIN) and alendronic acid (FOSAMAX) before and had allergy. The patient experienced fever and chills the next day on 19Mar2021 6.00AM - lymphadenopathy of neck and throat on the 2nd day (20Mar2021) - throat ulcers and ear pain on the third day (21Mar2021). The largest ulcer was about the size of a quarter. Continued low grade fever and pain and ulceration. AE resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient did not receive any treatment for AE. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab (pending results) on 22Mar2021. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Ear pain, Lymphadenopathy, Pharyngeal ulceration, Pyrexia
Clinical narrative: Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; This is a spontaneous report from a contactable other healthcare professional (patient). A 68-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration, administered in Arm Right on 18Mar2021 14:00 (at the age of 68-year-old) as single dose for covid-19 immunization. Medical history included Sepsis one year ago (2020), known allergies to eggs. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included melatonin taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5198), via an unspecified route of administration, administered in Arm Right on 25Feb2021 14:00 (at the age of 68-year-old) for covid-19 immunization. The patient also took hydromorphone (DILAUDID), levofloxacin (LEVAQUIN) and alendronic acid (FOSAMAX) before and had allergy. The patient experienced fever and chills the next day on 19Mar2021 6.00AM - lymphadenopathy of neck and throat on the 2nd day (20Mar2021) - throat ulcers and ear pain on the third day (21Mar2021). The largest ulcer was about the size of a quarter. Continued low grade fever and pain and ulceration. AE resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient did not receive any treatment for AE. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab (pending results) on 22Mar2021. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; Fever and chills the next day - lymphadenopathy of my neck and throat on the 2nd day - throat ulcers and ear pain on the third day. The largest ulcer is about the size of a quarter. Continued low grad; This is a spontaneous report from a contactable other healthcare professional (patient). A 68-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration, administered in Arm Right on 18Mar2021 14:00 (at the age of 68-year-old) as single dose for covid-19 immunization. Medical history included Sepsis one year ago (2020), known allergies to eggs. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included melatonin taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5198), via an unspecified route of administration, administered in Arm Right on 25Feb2021 14:00 (at the age of 68-year-old) for covid-19 immunization. The patient also took hydromorphone (DILAUDID), levofloxacin (LEVAQUIN) and alendronic acid (FOSAMAX) before and had allergy. The patient experienced fever and chills the next day on 19Mar2021 6.00AM - lymphadenopathy of neck and throat on the 2nd day (20Mar2021) - throat ulcers and ear pain on the third day (21Mar2021). The largest ulcer was about the size of a quarter. Continued low grade fever and pain and ulceration. AE resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient did not receive any treatment for AE. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included Nasal Swab (pending results) on 22Mar2021. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Swollen tongue, Tonsillar hypertrophy
Clinical narrative: Pt reports SOB, hives after initial Moderna vaccination at the Vaccination clinic.   After 5-10 minutes, she experienced a numbing, tingling, cold sensation in her throat and her throat swelled up. After 15 minutes, her tongue was visibly swollen. Able to swallow water and talk. Was given a shot of diphenhydramine at the vaccination site. Was transported to the ER via ambulance. Notes she felt dizziness and had increased blood pressure. Did not pass out. Had some tingling and coldness in her extremities. She was treated with diphenhydramine 50 IV in the ambulance and diphenhydramine 25 mg in the ER. No epinephrine. Was monitored in the ER for an hour. After she was discharged, patient felt a cold sensation and took cetirizine.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Dyspnoea, Feeling cold, Paraesthesia
Clinical narrative: Pt reports SOB, hives after initial Moderna vaccination at the Vaccination clinic.   After 5-10 minutes, she experienced a numbing, tingling, cold sensation in her throat and her throat swelled up. After 15 minutes, her tongue was visibly swollen. Able to swallow water and talk. Was given a shot of diphenhydramine at the vaccination site. Was transported to the ER via ambulance. Notes she felt dizziness and had increased blood pressure. Did not pass out. Had some tingling and coldness in her extremities. She was treated with diphenhydramine 50 IV in the ambulance and diphenhydramine 25 mg in the ER. No epinephrine. Was monitored in the ER for an hour. After she was discharged, patient felt a cold sensation and took cetirizine.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal hypoaesthesia, Pharyngeal paraesthesia, Pharyngeal swelling, Swollen tongue, Urticaria
Clinical narrative: Pt reports SOB, hives after initial Moderna vaccination at the Vaccination clinic.   After 5-10 minutes, she experienced a numbing, tingling, cold sensation in her throat and her throat swelled up. After 15 minutes, her tongue was visibly swollen. Able to swallow water and talk. Was given a shot of diphenhydramine at the vaccination site. Was transported to the ER via ambulance. Notes she felt dizziness and had increased blood pressure. Did not pass out. Had some tingling and coldness in her extremities. She was treated with diphenhydramine 50 IV in the ambulance and diphenhydramine 25 mg in the ER. No epinephrine. Was monitored in the ER for an hour. After she was discharged, patient felt a cold sensation and took cetirizine.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Chest X-ray normal, Computerised tomogram head, Dizziness, Electrocardiogram normal
Clinical narrative: Acute onset of dizziness while on a small boat on the water. Presented to ED at 10:00. CT of head and neck was normal; MRI was normal. Slow improvement of symptoms with meclizine. Ultimately discharged to home at 17:45. Given meclizine x 2, ondansetron 4mg IV, famotidine 20mg IV, diazepam 5mg IV, and metoclopramide 10mg IV x 2 over the course of his stay,
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling abnormal, Magnetic resonance imaging head normal, Presyncope, Tremor, Vertigo
Clinical narrative: Acute onset of dizziness while on a small boat on the water. Presented to ED at 10:00. CT of head and neck was normal; MRI was normal. Slow improvement of symptoms with meclizine. Ultimately discharged to home at 17:45. Given meclizine x 2, ondansetron 4mg IV, famotidine 20mg IV, diazepam 5mg IV, and metoclopramide 10mg IV x 2 over the course of his stay,
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Acute onset of dizziness while on a small boat on the water. Presented to ED at 10:00. CT of head and neck was normal; MRI was normal. Slow improvement of symptoms with meclizine. Ultimately discharged to home at 17:45. Given meclizine x 2, ondansetron 4mg IV, famotidine 20mg IV, diazepam 5mg IV, and metoclopramide 10mg IV x 2 over the course of his stay,
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Computerised tomogram neck, Dizziness, Magnetic resonance imaging normal, Metabolic function test
Clinical narrative: Acute onset of dizziness while on a small boat on the water. Presented to ED at 10:00. CT of head and neck was normal; MRI was normal. Slow improvement of symptoms with meclizine. Ultimately discharged to home at 17:45. Given meclizine x 2, ondansetron 4mg IV, famotidine 20mg IV, diazepam 5mg IV, and metoclopramide 10mg IV x 2 over the course of his stay,
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture, Myelitis transverse
Clinical narrative: Pfizer two shot first 1/28/21 second 2/18/21. Total numbness left leg on May 18, 2021. One week in hospital with steroid treatment. No change in leg mobility. PT for a week, wheelchair, walker, cane now walking without but not good muscle control.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Laboratory test normal, Lumbar puncture normal, Mobility decreased, Nerve injury
Clinical narrative: Pfizer two shot first 1/28/21 second 2/18/21. Total numbness left leg on May 18, 2021. One week in hospital with steroid treatment. No change in leg mobility. PT for a week, wheelchair, walker, cane now walking without but not good muscle control.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Walking aid user, Wheelchair user
Clinical narrative: Pfizer two shot first 1/28/21 second 2/18/21. Total numbness left leg on May 18, 2021. One week in hospital with steroid treatment. No change in leg mobility. PT for a week, wheelchair, walker, cane now walking without but not good muscle control.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: nauseous; definitely achy; fever/101.3 fever/feverish; feels un well/I was feeling a little off; chills; sore; tiredness.; Flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 23Mar2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller reported that she received the second dose of vaccine yesterday afternoon. Today (24Mar2021) she had a fever of 101.3, and she felt unwell. Caller reported that she took Tylenol. She said last night (23Mar2021) she was feeling a little off. She woke up, she had chills, achy and sore all night and she woke up this morning (24Mar2021) with 101.3 fever and just feeling off like little nauseous and definitely achy and feverish. Reporter (patient) was experiencing flu-like symptoms like 101.3°F fever, body aches and tiredness. She would like to report these symptoms. She also was asking if she can infect her son who was at home. The patient underwent lab tests and procedures which included body temperature: 101.3 Fahrenheit on 24Mar2021. Therapeutic measures were taken as a result of pyrexia, malaise, nausea, definitely achy, feverish and chills. The outcome of all events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Fatigue, Influenza like illness, Malaise
Clinical narrative: nauseous; definitely achy; fever/101.3 fever/feverish; feels un well/I was feeling a little off; chills; sore; tiredness.; Flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 23Mar2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller reported that she received the second dose of vaccine yesterday afternoon. Today (24Mar2021) she had a fever of 101.3, and she felt unwell. Caller reported that she took Tylenol. She said last night (23Mar2021) she was feeling a little off. She woke up, she had chills, achy and sore all night and she woke up this morning (24Mar2021) with 101.3 fever and just feeling off like little nauseous and definitely achy and feverish. Reporter (patient) was experiencing flu-like symptoms like 101.3°F fever, body aches and tiredness. She would like to report these symptoms. She also was asking if she can infect her son who was at home. The patient underwent lab tests and procedures which included body temperature: 101.3 Fahrenheit on 24Mar2021. Therapeutic measures were taken as a result of pyrexia, malaise, nausea, definitely achy, feverish and chills. The outcome of all events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.